Severe pembrolizumab-associated neutropenia after CD34⁺ selected allogeneic hematopoietic-cell transplantation for multiple myeloma. Article

Overview

authors

publication date

March 7, 2018

published in

Bone marrow transplantation Journal

Research

keywords

Antibodies, Monoclonal, Humanized
Antigens, CD34
Antineoplastic Agents, Immunological
Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Neutropenia
Transplantation, Autologous
Transplantation, Homologous

Identity

PubMed Central ID

PMC6984164

Scopus Document Identifier

85042915936

Digital Object Identifier (DOI)

10.1038/s41409-018-0142-4

PubMed ID

29515248

Additional Document Info

has global citation frequency

6

volume

53

issue

8